Shares of International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.09, with a volume of 4,007 shares.
International Stem Cell Price Performance
The company has a market capitalization of $728,000.00, a P/E ratio of -1.14 and a beta of 0.17. The company has a fifty day simple moving average of $0.09 and a two-hundred day simple moving average of $0.08.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- What to Know About Investing in Penny Stocks
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- What is the Dogs of the Dow Strategy? Overview and Examples
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- How to Invest in Biotech Stocks
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
